The nuclear expression level of YBX1 and an increased total YBX1 expression level are predictive markers for poor prognosis in patients with breast cancer [19, 21, 23, 27, 28], ovarian cancer [34], prostate cancer [35], and other human malignancies [36]. Here, YBX1 is linked to prostate cancer.